首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1578148

全球藥用賦形劑市場規模、成長率和趨勢分析：依功能、應用和產品的預測（至2032年）

Global Pharmaceutical Excipients Market Size, Growth and Trends Analysis by Function, Application, Product - Industry Forecast 2032

出版日期: 2024年09月24日 | 出版商:

Market Research Future | 英文 262 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

藥用賦形劑市場規模2023年為92.7億美元，預計將從2024年的100.2億美元，在預測期內年複合成長率為7.03%，到2032年將成長到184.8億美元規模。

對多功能賦形劑的需求不斷成長以及仿製藥使用的增加是推動市場擴張的主要因素。

藥用賦形劑也用於增強藥物的風味，提高依從性，尤其是年輕患者的依從性。藥物賦形劑可以來自有機和無機來源，這取決於它們的化學成分。對功能性賦形劑的需求不斷成長、最近的專利到期以及奈米技術的快速進步是推動藥用賦形劑市場的主要因素。將賦形劑添加到含有少量藥物的固體劑型中，以實現長期穩定、增強最終劑型中活性成分的效力以及其他目的。此外，賦形劑也用於改善藥物製劑的性質，例如增加藥物溶解度、降低黏度和改善藥物吸收。

依地域的展望

預計2022年歐洲藥用賦形劑市場規模將達到 25.1億美元，並以顯著的年複合成長率成長。隨著藥品專利到期日的臨近，許多歐洲國家都開始關注仿製藥產業。德國、英國和法國等歐洲國家預計在預測期內將呈現顯著的成長率。預計該地區對藥用賦形劑的需求將越來越大。

北美在藥用賦形劑市場佔有第二大佔有率。在預測期內，由於製藥業的快速發展、對功能性添加劑的需求不斷成長、行業領先企業的存在、技術進步等，預計市場將大幅成長。

估計2024年至2032年，亞太地區藥用賦形劑市場將以最快的年複合成長率成長。

本報告調查了全球藥用賦形劑市場，提供市場的定義和概述，市場成長的各種影響因素分析，市場規模推移和預測，各種區分、地區/主要國家的細分，競爭環境，主要企業概況等彙整資料。

The size of the pharmaceutical excipients market was estimated at USD 9.27 billion in 2023 and is expected to increase at a compound annual growth rate (CAGR) of 7.03% from 2024 to 2032, from USD 10.02 billion in 2024 to USD 18.48 billion by 2032. The growing need for multifunctional excipients and the growing use of generic drugs are the primary factors propelling market expansion.

Furthermore, the market for pharmaceutical excipients is used to enhance the medication's flavor, which increases patient compliance, especially in young patients. Pharmaceutical excipients can come from both organic and inorganic sources, depending on their chemical composition. The growing need for functional excipients, recent patent expirations that increase consumer demand for pharmaceutical excipients, and the rapid advancement of nanotechnology are the primary factors propelling the pharmaceutical excipients market. For long-term stabilization, to increase the potency of the active ingredient in the final dosage form, or for any other purpose, excipients can be added to solid formulations that contain small APIs. Additionally, excipients are used to improve the properties of medicinal formulations, including increasing API solubility, decreasing viscosity, and improving drug absorption.

Market Segments Insights

Pharmaceutical fillers, binders, coatings, disintegrants, preservatives, and others are among the market sectors for pharmaceutical excipients based on their operational roles.

By-products have been separated into organic and inorganic compounds according to market data for pharmaceutical excipients.

The pharmaceutical excipients market has been divided into several segments based on applications, including parenteral, topical, and oral.

Regional Perspectives

The market insights by region in the survey encompass Asia-Pacific, Europe, North America, and the rest of the globe. The pharmaceutical excipients market in Europe was estimated to be worth USD 2.51 billion in 2022 and was projected to grow at a significant compound annual growth rate. Many European nations concentrate on the generics industry because of the approaching expiration dates of pharmaceutical patents. Therefore, it is expected that European nations such as Germany, the United Kingdom, France, and others will have notable growth rates over the forecast period. Pharmaceutical excipients are expected to become more and more necessary in the region.

North America has the second-largest proportion of the pharmaceutical excipients market. Over the course of the projection period, the market is expected to increase significantly due to the quickly increasing pharmaceutical sector, rising demand for functional excipients, strong competitors in the industry, and technological advancements.

The Asia-Pacific pharmaceutical excipients market is projected to grow at the fastest compound annual growth rate (CAGR) from 2024 to 2032. According to a recent study, China's overall revenue from traditional pharmaceutical sales is expected to increase over the coming years.

Key Players

Evonik Industries Ag, Basf Se, Ferro Corporation, P&G Chemicals, Akzo Nobel NV, FMC Corporation, The Dow Chemical Company, Ashland, Inc., and Croda International PLC are a few of the major players in the pharmaceutical excipients industry.

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. DEFINITION
2.2. SCOPE OF THE STUDY
- 2.2.1. RESEARCH OBJECTIVE
- 2.2.2. ASSUMPTIONS
- 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

3.1. OVERVIEW
3.2. DATA MINING
3.3. SECONDARY RESEARCH
3.4. PRIMARY RESEARCH
- 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
3.5. FORECASTING TECHNIQUE
3.6. MARKET SIZE ESTIMATION
- 3.6.1. BOTTOM-UP APPROACH
- 3.6.2. TOP-DOWN APPROACH
3.7. DATA TRIANGULATION
3.8. VALIDATION

4. MARKET DYNAMICS

4.1. OVERVIEW
4.2. DRIVERS
4.3. RESTRAINTS
4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

5.1. VALUE CHAIN ANALYSIS
5.2. PORTER'S FIVE FORCES ANALYSIS
- 5.2.1. BARGAINING POWER OF SUPPLIERS
- 5.2.2. BARGAINING POWER OF BUYERS
- 5.2.3. THREAT OF NEW ENTRANTS
- 5.2.4. THREAT OF SUBSTITUTES
- 5.2.5. INTENSITY OF RIVALRY
5.3. COVID-19 IMPACT ANALYSIS
- 5.3.1. MARKET IMPACT ANALYSIS
- 5.3.2. REGIONAL IMPACT
- 5.3.3. OPPORTUNITY AND THREAT ANALYSIS

6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE

6.1. OVERVIEW
6.2. PHARMACEUTICAL FILLERS
6.3. BINDERS
6.4. COATINGS
6.5. DISINTEGRANTS
6.6. PRESERVATIVES
6.7. OTHERS

7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

7.1. OVERVIEW
7.2. ORGANIC CHEMICALS
7.3. INORGANIC CHEMICALS

8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION

8.1. OVERVIEW
8.2. ORAL
8.3. TOPICAL
8.4. PARENTERAL
8.5. OTHERS

9. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

9.1. OVERVIEW
9.1. NORTH AMERICA
- 9.1.1. US
- 9.1.2. CANADA
9.2. EUROPE
- 9.2.1. GERMANY
- 9.2.2. FRANCE
- 9.2.3. UK
- 9.2.4. ITALY
- 9.2.5. SPAIN
- 9.2.6. REST OF EUROPE
9.3. ASIA-PACIFIC
- 9.3.1. CHINA
- 9.3.2. INDIA
- 9.3.3. JAPAN
- 9.3.4. SOUTH KOREA
- 9.3.5. AUSTRALIA
- 9.3.6. REST OF ASIA-PACIFIC
9.4. REST OF THE WORLD
- 9.4.1. MIDDLE EAST
- 9.4.2. AFRICA
- 9.4.3. LATIN AMERICA

10. COMPANY LANDSCAPE

10.1. OVERVIEW
10.2. COMPETITIVE ANALYSIS
10.3. MARKET SHARE ANALYSIS
10.4. MAJOR GROWTH STRATEGY IN THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
10.5. COMPETITIVE BENCHMARKING
10.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
10.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
- 10.7.1. NEW PRODUCT LAUNCH
- 10.7.2. MERGER & ACQUISITIONS
- 10.7.3. JOINT VENTURES
10.8. MAJOR PLAYERS FINANCIAL MATRIX
- 10.8.1. SALES & OPERATING INCOME,
- 10.8.2. MAJOR PLAYERS R&D EXPENDITURE.

11. COMPANY PROFILES

11.1. EVONIK INDUSTRIES AG
- 11.1.1. COMPANY OVERVIEW
- 11.1.2. FINANCIAL OVERVIEW
- 11.1.3. PRODUCT OFFERED
- 11.1.4. KEY DEVELOPMENTS
- 11.1.5. SWOT ANALYSIS
- 11.1.6. KEY STRATEGIES
11.2. BASF SE
- 11.2.1. COMPANY OVERVIEW
- 11.2.2. FINANCIAL OVERVIEW
- 11.2.3. PRODUCT OFFERED
- 11.2.4. KEY DEVELOPMENTS
- 11.2.5. SWOT ANALYSIS
- 11.2.6. KEY STRATEGIES
11.3. FERRO CORPORATION
- 11.3.1. COMPANY OVERVIEW
- 11.3.2. FINANCIAL OVERVIEW
- 11.3.3. PRODUCT OFFERED
- 11.3.4. KEY DEVELOPMENTS
- 11.3.5. SWOT ANALYSIS
- 11.3.6. KEY STRATEGIES
11.4. P&G CHEMICALS
- 11.4.1. COMPANY OVERVIEW
- 11.4.2. FINANCIAL OVERVIEW
- 11.4.3. PRODUCT OFFERED
- 11.4.4. KEY DEVELOPMENTS
- 11.4.5. SWOT ANALYSIS
- 11.4.6. KEY STRATEGIES
11.5. FMC CORPORATION
- 11.5.1. COMPANY OVERVIEW
- 11.5.2. FINANCIAL OVERVIEW
- 11.5.3. PRODUCT OFFERED
- 11.5.4. KEY DEVELOPMENTS
- 11.5.5. SWOT ANALYSIS
- 11.5.6. KEY STRATEGIES
11.6. THE DOW CHEMICAL COMPANY
- 11.6.1. COMPANY OVERVIEW
- 11.6.2. FINANCIAL OVERVIEW
- 11.6.3. PRODUCT OFFERED
- 11.6.4. KEY DEVELOPMENTS
- 11.6.5. SWOT ANALYSIS
- 11.6.6. KEY STRATEGIES
11.7. ASHLAND, INC.
- 11.7.1. COMPANY OVERVIEW
- 11.7.2. FINANCIAL OVERVIEW
- 11.7.3. PRODUCT OFFERED
- 11.7.4. KEY DEVELOPMENTS
- 11.7.5. SWOT ANALYSIS
- 11.7.6. KEY STRATEGIES
11.8. CRODA INTERNATIONAL PLC
- 11.8.1. COMPANY OVERVIEW
- 11.8.2. FINANCIAL OVERVIEW
- 11.8.3. PRODUCT OFFERED
- 11.8.4. KEY DEVELOPMENTS
- 11.8.5. SWOT ANALYSIS
- 11.8.6. KEY STRATEGIES
11.9. AKZO NOBEL NV
- 11.9.1. COMPANY OVERVIEW
- 11.9.2. FINANCIAL OVERVIEW
- 11.9.3. PRODUCT OFFERED
- 11.9.4. KEY DEVELOPMENTS
- 11.9.5. SWOT ANALYSIS
- 11.9.6. KEY STRATEGIES
11.10. INNOPHOS
- 11.10.1. COMPANY OVERVIEW
- 11.10.2. FINANCIAL OVERVIEW
- 11.10.3. PRODUCT OFFERED
- 11.10.4. KEY DEVELOPMENTS
- 11.10.5. SWOT ANALYSIS
- 11.10.6. KEY STRATEGIES

12. APPENDIX

12.1. REFERENCES
12.2. RELATED REPORTS

簡介目錄圖表

LIST OF TABLES

TABLE 1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD MILLION)
TABLE 3 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 7 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 9 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 10 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 11 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 12 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 13 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 14 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 15 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 16 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 17 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019-2032 (USD MILLION)
TABLE 18 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 19 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 20 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 21 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 22 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 23 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 24 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 25 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 26 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 27 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 28 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 29 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 30 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 31 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 32 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 33 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 34 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 35 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 36 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 37 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 38 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 39 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 40 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 41 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 42 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 43 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 44 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 45 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 46 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 47 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 48 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 49 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 50 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 51 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 52 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 53 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 54 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 55 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 56 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 57 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 58 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 59 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 60 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 61 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 62 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 63 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019-2032 (USD MILLION)
TABLE 64 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 65 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 66 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 67 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 68 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 69 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 70 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 71 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 72 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 73 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019-2032 (USD MILLION)
TABLE 74 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 75 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
FIGURE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY FUNCTION,
FIGURE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY PRODUCT,
FIGURE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY APPLICATION,
FIGURE 7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY REGION,
FIGURE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
FIGURE 9 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
FIGURE 10 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
FIGURE 11 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY,
FIGURE 12 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY SHARE ANALYSIS (%),
FIGURE 13 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 EVONIK INDUSTRIES AG: SWOT ANALYSIS
FIGURE 15 BASF SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 BASF SE: SWOT ANALYSIS
FIGURE 17 P&G CHEMICALS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 P&G CHEMICALS: SWOT ANALYSIS
FIGURE 19 AKZO NOBEL NV, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 AKZO NOBEL NV, INC: SWOT ANALYSIS
FIGURE 21 FMC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 FMC CORPORATION: SWOT ANALYSIS
FIGURE 23 THE DOW CHEMICAL COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 THE DOW CHEMICAL COMPANY: SWOT ANALYSIS
FIGURE 25 ASHLAND, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 ASHLAND, INC.: SWOT ANALYSIS
FIGURE 27 CRODA INTERNATIONAL PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 CRODA INTERNATIONAL PLC: SWOT ANALYSIS
FIGURE 29 FERRO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 FERRO CORPORATION: SWOT ANALYSIS
FIGURE 31 INNOPHOS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 INNOPHOS: SWOT ANALYSIS